Scottish Medicines Consortium Approves CAR T-cell Therapy for Blood Cancer
First car t-cell therapy accepted for second-line treatment in Scotland.
The Scottish Medicines Consortium (SMC) has approved Kite’s CAR T-cell therapy, Y...


















